Analysts’ recommendations and target price

Wall Street analysts expect an upside potential of 107.39% for Opko Health (OPK) based on the company’s closing price on March 26. In 2019, analysts revised downwards the company’s target price from $10.00 in January and February to $5.33 in March. The current consensus analyst recommendation for the stock is a “strong buy.”

Analysts Drastically Reduced Target Price for Opko Health in March

Of the three analysts covering Opko Health, two are recommending a “strong buy,” and one analyst is recommending a “buy.” On March 26, Opko Health closed at $2.57, 1.98% higher than its previous closing price, 10.06% higher than its 52-week low of $2.34 and 59.84% lower than its 52-week high of $6.40. The company’s market capitalization is $1.70 billion.

Based on its closing price on March 26, Opko Health has reported returns of 2.39% in the last week, -9.51% in the last month, and 0.39% in the last quarter. The company has reported returns of -40.51% in the last half year, -27.20% in the last year, and -14.62% YTD.

Recent stock price movements

In its fourth quarter, Opko Health reported revenues of $221.90 million, a YoY rise of 14.56% but lower than the consensus estimate by $23.37 million. The company reported non-GAAP EPS of -$0.13, which was lower than the consensus estimate by $0.04. After its fourth-quarter earnings announcement on February 27, the company’s share price declined to $2.78  from $2.83 on the previous day. The stock further slipped to $2.55 on February 28.

On March 21, Opko Health issued a press release announcing positive top-line results from the phase 2 trial evaluating investigational injectable therapy OPK88003 in the obesity and type 2 diabetes indication. Thereafter, the company’s stock price closed at $2.72 on March 21, 10.57% higher than its previous closing price.

Latest articles

The Dow Jones Industrial Average fell 53.44 points (or 0.2%) today, possibly because the market gave a thumbs up to yesterday's 0.25% rate cut by the Fed.

If there’s one thing critics and fans agree on when it comes to Bitcoin, it’s the volatility factor. The moves are big, and timid investors need not apply.

In this year’s annual shareholder letter, Berkshire Hathaway (BRK.B) CEO Warren Buffett discussed the possibility of an “elephant-sized acquisition."

The esports industry is thriving. Let's take a look at the expected growth in esports viewership and the total available market in the space.

Today, Jeff Bezos detailed Amazon's plans for sweeping sustainability initiatives. Bezos's announcement came a day before the Global Climate Strike.

Integrated oil companies ExxonMobil and Chevron have strong upstream portfolios, which play a vital role in determining their profitabilities.